N/A
Manufactured by Covis Pharma US, Inc
74,022 FDA adverse event reports analyzed
Last updated: 2026-04-14
CICLESONIDE is a medication tracked in the FDA Adverse Event Reporting System (FAERS), manufactured by Covis Pharma US, Inc. The most commonly reported adverse reactions for CICLESONIDE include ASTHMA, DYSPNOEA, WHEEZING, THERAPEUTIC PRODUCT EFFECT INCOMPLETE, COUGH. This page provides a comprehensive breakdown of reported side effects, safety signals, patient demographics, and AI-powered safety analysis for CICLESONIDE.
Out of 13,073 classified reports for CICLESONIDE:
The FDA classifies an adverse event as “serious” if it results in death, hospitalization, disability, congenital anomaly, or requires intervention to prevent permanent damage.
Demographics reflect voluntary FDA adverse event reporting patterns and may not represent the full patient population.
This profile reflects 74,022 FDA FAERS reports that mention CICLESONIDE. Reporting is voluntary and does not prove that the drug caused any listed event.
Frequently reported terms in FAERS include ASTHMA, DYSPNOEA, WHEEZING, THERAPEUTIC PRODUCT EFFECT INCOMPLETE, COUGH, OBSTRUCTIVE AIRWAYS DISORDER. Rankings reflect reporting volume in this dataset, not confirmed side effect rates in the general population.
Labeling and FAERS entries often list Covis Pharma US, Inc in connection with CICLESONIDE. Always verify the specific product and NDC with your pharmacist.